期刊文献+

结外鼻型NK/T细胞淋巴瘤30例诊疗分析 被引量:6

Analysis of diagnosis and treatment of 30 patients with extranodal NK/T-cell lymphoma, nasal type
原文传递
导出
摘要 目的 探讨结外鼻型NK/T细胞淋巴瘤的临床特征及预后影响因素.方法 对按照WHO淋巴瘤分类标准,经病理确诊的30例结外鼻型NK/T细胞淋巴瘤患者临床特点、长期生存率、预后因素进行分析.结果 30例结外鼻型NK/T细胞淋巴瘤患者,以男性患者居多,中位发病年龄45岁,年轻患者鼻外型较多见,且更易合并噬血细胞综合征.实验室检查发现白细胞、血红蛋白、血小板、丙氨酸氨基转移酶、乳酸脱氢酶、清蛋白常有异常,且在生存组与死亡组之间,血红蛋白下降、血清清蛋白下降程度的差异有统计学意义.死亡患者发病年龄相对较轻,鼻外型多见,更多伴B症状、噬血细胞综合征,国际预后指数(IPI)评分较高,骨髓累及发生率较高,临床分期更晚,实验室检查异常更多.Kaplan-Meier单因素分析显示发病年龄、是否鼻腔来源、有无B症状、有无骨髓累及、是否伴发噬血细胞综合征、IPI评分、临床分期、治疗方法,以及有无白细胞、血红蛋白、血小板、血清乳酸脱氢酶、清蛋白水平异常,有无肝功能损伤等因素,均可影响预后;采用Cox回归模型进行多因素预后分析,显示有无血清LDH升高及有无骨髓累及为影响预后的独立危险因素.结论 结外鼻型NK/T细胞淋巴瘤多见于中年男性,侵袭性高,病初临床表现多样.相比鼻腔NK/T细胞淋巴瘤患者,鼻外型患者发病年龄更轻,实验室异常更明显,更易伴发噬血细胞综合征,更易累及骨髓,预后更差.有无血清LDH升高及有无骨髓累及为影响预后的独立危险因素. Objective To analyze the clinical characteristics of extranodal NK/T-cell lymphoma,nasal type,and its prognostic factors.Methods 30 patients with extranodal NK/T-cell lymphoma,nasal type were collected according to the WHO lymphoma classification criteria.The clinical characteristics,long-term survival rates and prognostic factors of the 30 patiets were analyzed.Results Extranodal NK/T-cell lymphoma,nasal type usually affected male patients,male to female ratio was approximately 4∶1,at a median age of 45 years old.The young patients was more common to merge the hemophagocytic syndrome.Extranodal NK/T-cell lymphoma might invole any anatomic site.Laboratory examination revealed white blood cell,hemoglobin,platelet,alanine aminotransferase,lactate dehydrogenase,albumin abnormalities.Between survival and death groups,hemoglobin abnormalities and albumin decreases might be meaningful.15 patients died at last,with ligter onset age,more common with extrnose type,and more with B symptoms,hemophagocytic syndrome,higher IPI scores,higher bone marrow involvingrate,later clinical stage,more abnormal laboratory tests.Kaplan-Meier univariate analysis found these factors can affect the prognosis,including the onset age,whether nasal sources,with or without B symptoms,IPI scores,associated hemophagocytic syndrome,with or without bone marrow involved,clinical stage,treatment methods,as well as white blood cells,hemoglobin,platelet levels,serum lactate dehydrogenase,albumin,with or without liver dysfunction and other factors.But the Cox regession multivariate prognostic analysis showed that serum lactate dehydrogenase levels and the presence of bone marrow involving were the independent prognostic risk factors.Conclusions Extranodal NK/T-cell lymphoma,nasal type is invasive,and more common in middle-aged men,it may have diverse clinical manifestations with early stage.Compared to nasal cavity NK/T cell lymphoma,extranasal type appearances in patients with lighter onset age,more pronounced laboratory abnormalities,more associated with hemophagocytic syndrome,more involved bone marrow,and with a worse prognosis.The serum lactate dehydrogenase levels and the presence of bone marrow involving are the independent prognostic risk factors.
出处 《白血病.淋巴瘤》 CAS 2013年第12期724-728,共5页 Journal of Leukemia & Lymphoma
基金 国家自然科学基金(81270653) 首都医学发展科研基金(2009-1032) 中华医学会关于临床医学科研专项资金(11010020246) 北京友谊医院科研启动基金(YYQDKT2011-6)
关键词 结外NK T细胞淋巴瘤 鼻型 临床特征 预后 Extranodal NK/T-cell lymphoma, nasal type Clinical characteristics Prognosis
  • 相关文献

参考文献13

  • 1Jaffe ES,Chan JK,Su IJ,et al.Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas Definitions,differential diagnosis,and epidemiology.Am J Surg Pathol,1996,20:103-111.
  • 2Avilés A,Díaz NR,Neff N,et al.Angioeentric nasal T/natural killer cell lymphoma:a single center study of prognostic factors in 108 patients.Clin Lab Haematol,2000,22:215-220.
  • 3Janka GE.Familial and acquired hemophagocytic lymphohistiocytosis.Eur J Pediatr,2007,166:95-109.
  • 4Chan JK,Sin VC,Wong KF,et al.Nonnasal lymphoma expressing the natural killer cell marker CD56:a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.Blood,1997,89:4501-4513.
  • 5Ma HH,Qian LT,Pan HF,et al.Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/Tcell lymphoma.Med Oncol,2010,27:798-806.
  • 6Kim SJ,Kim BS,Choi CW,et al.Treatment outcome of front-line systemic chemotherapy for localized ectrnodal NK/T cell lymphoma in nasal and upper aerodigestive tract.Leuk Lymphoma,2006,47:1265-1273.
  • 7Kim SJ,Kim K,Kim BS,et al.Phase Ⅱ trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed,stage Ⅰ E to Ⅱ E,nasal,extranonal NK/T-Cell Lymphoma:Consortium for Improving Survival of Lymphoma study.J Clin Oncol,2009,27:6027-6032.
  • 8WuX,LiP,ZhaoJ,etal.A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma,nasal type.Clin Oncol (R Coll Radiol),2008,20:619-625.
  • 9Yamaguchi M,Suzuki R,Kwong YL,et al.Phase Ⅰ study of dexamethasone,methotrexate,ifosfamide,L-asparaginase,and etoposide (SMILE) chemotherapy for advanced-stage,relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.Cancer Sci,2008,99:1016-1020.
  • 10Yamaguchi M,Kwong YL,Kim WS,et al.Phase Ⅱ study of SMILE chemotherapy for newly diagnosed stage Ⅳ,relapsed,or refractory extranodal natural killer (NK)/T-cell lymphoma,nasal type:the NK-Cell Tumor Study Group study.J Clin Oncol,2011,29:4410-4416.

同被引文献78

  • 1朱光辉,钱江潮,程黎萍,王增寿,章佳珠,李原.甲氨蝶呤致脑脊髓炎2例[J].儿科药学杂志,2004,10(5):56-56. 被引量:1
  • 2金晶,李晔雄,姚波,房辉,刘新帆,周立强,吕宁,余子豪.ⅠE~ⅡE期鼻腔NK/T细胞淋巴瘤的放疗效果分析[J].中华放射肿瘤学杂志,2006,15(2):108-113. 被引量:24
  • 3Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008 : an overview. Pathologica, 2010,102 : 83-87.
  • 4Yasuda H, Sugimoto K, Imai H, ct al. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma. Eur J Haematol, 2009,82 : 39-45.
  • 5Au WY, Weiseuburger DD, IutrM,,umtoruchai T, et al. Clirtical differences between nasal and extranasal natural killer/T-cell lymphoma:a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood, 2009,113 : 3931 - 3937.
  • 6Moon SH, Cho SK, Kim WS, et al. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods. J Nucl Med, 2013,54: 1039-1044.
  • 7Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol, 2007,25:579- 586.
  • 8Kohrt H, Advani R. Extranodal natural killer/T-cell lymphoma :current concepts in biology and treatment. Leuk Lymphoma, 2009,50 : 1773-1784.
  • 9Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol, 2006,24 : 612-618.
  • 10Li ZM, Zhu YJ, Sun J, et al, Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma. Ann Hematol, 2012,91 : 1265-1270.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部